Anthrax edema factor toxicity is strongly mediated by the N-end rule.

Anthrax edema factor (EF) is a calmodulin-dependent adenylate cyclase that converts adenosine triphosphate (ATP) into 3'-5'-cyclic adenosine monophosphate (cAMP), contributing to the establishment of Bacillus anthracis infections and the resulting pathophysiology. We show that EF adenylate cyclase toxin activity is strongly mediated by the N-end rule, and thus is dependent on the identity of the N-terminal amino acid. EF variants having different N-terminal residues varied by more than 100-fold in potency in cultured cells and mice. EF variants having unfavorable, destabilizing N-terminal residues showed much greater activity in cells when the E1 ubiquitin ligase was inactivated or when proteasome inhibitors were present. Taken together, these results show that EF is uniquely affected by ubiquitination and/or proteasomal degradation.
AuthorsClinton E Leysath, Damilola D Phillips, Devorah Crown, Rasem J Fattah, Mahtab Moayeri, Stephen H Leppla
JournalPloS one (PLoS One) Vol. 8 Issue 8 Pg. e74474 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID24015319 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Antigens, Bacterial
  • Bacterial Toxins
  • anthrax toxin
  • Proteasome Endopeptidase Complex
  • Adenylyl Cyclases
  • Ubiquitin-Protein Ligases
  • Adenylyl Cyclases (genetics, metabolism)
  • Animals
  • Antigens, Bacterial (genetics, metabolism)
  • Bacillus anthracis (enzymology, genetics)
  • Bacterial Toxins (genetics, metabolism)
  • Cell Line
  • Mice
  • Proteasome Endopeptidase Complex (metabolism)
  • Proteolysis
  • Ubiquitin-Protein Ligases (metabolism)
  • Ubiquitination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: